Imperial College London Featured PhD Programmes
Xi’an Jiaotong-Liverpool University Featured PhD Programmes
University of Warwick Featured PhD Programmes
Heriot-Watt University Featured PhD Programmes
University of Reading Featured PhD Programmes

Biological & Medical Sciences PhD Projects, Programs & Scholarships in Hull

We have 19 Biological & Medical Sciences PhD Projects, Programs & Scholarships in Hull

  • Biological & Medical Sciences×
  • United Kingdom×
  • Hull×
  • clear all
Order by 
Showing 11 to 19 of 19
  Platelets and hypoxia: how do varying oxygen concentrations affect platelet function and signalling?
  Dr M Arman
Applications accepted all year round

Funding Type

PhD Type

Platelets have key functions in regulating haemostasis and maintaining vascular integrity, which can cause cardiovascular disease if unbalanced.
  Re-purposing diabetes medicines to manage bleeding complications in myeloproliferative neoplasms.
  Prof Tim Palmer, Dr D Allsup
Application Deadline: 31 March 2020

Funding Type

PhD Type

Myeloproliferative neoplasms (MPNs) are a group of three related blood cancers in which the bone marrow overproduces one of the three cellular components of blood (erythrocytes, leukocytes and platelets).
  Epidemiology of common endocrine disorders and diabetes
  Dr T Sathyapalan
Applications accepted all year round

Funding Type

PhD Type

A PhD project is available in Prof Sathyapalan group with a focus on the epidemiology of common endocrine disorders and diabetes at the University of Hull.
  Precision-cut lung slices to investigate the effect of human rhinovirus on cough and airway inflammation
  Dr L Sadofsky
Application Deadline: 31 March 2020

Funding Type

PhD Type

The human Rhinovirus (RV) is the major cause of the common cold. There are no current treatments or vaccines for the virus other than over the counter preparations to alleviate symptoms.
  Modulation of platelet-mediated innate immune responses in chronic lymphocytic leukaemia
  Dr M Arman
Application Deadline: 31 March 2020

Funding Type

PhD Type

Chronic lymphocytic leukaemia (CLL) is the most common form of leukaemia in the Western World. B-cell receptor-induced intracellular signals are critical for the survival of leukaemia cells and disruption of this pathway by the Bruton’s tyrosine kinase (Btk) inhibitor ibrutinib is a highly effective CLL therapy.
  Investigating models of survivorship care for patients with haematological malignancie.
  Dr D Allsup
Application Deadline: 31 March 2020

Funding Type

PhD Type

The haematological cancers lymphoma, leukaemia and myeloma represent 8% of all cancers and collectively are the fifth commonest cancer.
  Identification of novel glucose-dependent alterations responsible for vascular dysfunction in Type 2 diabetes.
  Prof Tim Palmer, Dr R Sturmey
Application Deadline: 31 March 2020

Funding Type

PhD Type

Diabetes is a growing global healthcare problem. The majority of people living with diabetes have Type 2 diabetes mellitus (T2DM), characterised by a resistance of the body to the action of insulin.
  Identification of novel glucose-dependent alterations responsible for platelet dysfunction in Type 2 diabetes.
  Prof Tim Palmer, Dr F Rivero
Application Deadline: 31 March 2020

Funding Type

PhD Type

Type 2 diabetes mellitus (T2DM) is a growing global healthcare problem. Clinical findings suggest that more than 70% of patients with T2DM will die of cardiovascular diseases (CVDs) including heart attack and stroke.
  How does the vascular matrix environment influence platelet activation?
  Dr S Calaminus
Application Deadline: 31 March 2020

Funding Type

PhD Type

The platelet is a blood cell that plays a key role in the prevention of bleeding. For platelets to form a clot or thrombus effectively, they must rearrange their actin cytoskeleton to withstand high shear stress from blood flow in the arteries.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2020
All rights reserved.